Mutual Of America Capital Management LLC Protagonist Therapeutics, Inc Transaction History
Mutual Of America Capital Management LLC
- $9.32 Billion
- Q3 2024
A detailed history of Mutual Of America Capital Management LLC transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Mutual Of America Capital Management LLC holds 8,860 shares of PTGX stock, worth $411,990. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,860Holding current value
$411,990% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PTGX
# of Institutions
222Shares Held
59.3MCall Options Held
19KPut Options Held
107K-
Farallon Capital Management LLC San Francisco, CA5.84MShares$272 Million0.98% of portfolio
-
Black Rock Inc. New York, NY5.76MShares$268 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.29MShares$246 Million3.06% of portfolio
-
Bvf Inc San Francisco, CA3.32MShares$154 Million3.52% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.24MShares$151 Million0.0% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $2.28B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...